A study in Nature Biotechnology suggests that rentosertib, a drug designed with AI by Insilico Medicine, may reverse markers of biological aging. Six independent aging clocks predicted that treated patients were biologically up to six years younger than the placebo group. The trial covered just 42 patients and the drug hasn't been tested in healthy people yet.
The article AI-designed drug appears to turn back the body's biological clock in early trial appeared first on The Decoder.
source & further reading
the-decoder.com — original article
At UBS, AI skills are now a condition for landing a job
Qwen-Drive 1.0 tells you why it brakes, just don't expect the explanation to match the maneuver
Meta's new real-time audio model is the foundation for AI assistants that never stop listening